SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01099 SINOPHARM

Market Closed 10-02 16:08:09

14.730

-0.130

-0.87%

High14.980	Low14.580	Vol5.28M
Open14.860	D1 Closing14.860	Amplitude2.69%
Mkt Cap45.97B	Tradable Cap19.76B	Total Shares3.12B
T/O77.68M	T/O Rate0.39%	Tradable Shares1.34B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01099","market":"HK","secType":"STK","nameCN":"SINOPHARM","latestPrice":14.73,"timestamp":1790928489003,"preClose":14.86,"halted":0,"volume":5282309,"delay":0,"changeRate":-0.008748317631224698,"floatShares":1341810740,"shares":3121000000,"eps":2.29,"marketStatus":"Market Closed","change":-0.13,"latestTime":"10-02 16:08:09","open":14.86,"high":14.98,"low":14.58,"amount":77679744,"amplitude":0.026918,"askPrice":14.74,"askSize":13200,"bidPrice":14.73,"bidSize":91200,"shortable":3,"etf":0,"ttmEps":2.620836,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":7,"adr":0,"listingDate":1253635200000,"exchange":"SEHK","adjPreClose":14.86,"dividendRate":0.053625,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":1.3249679952373914,"lotSize":400,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SNP.HK","impliedVol":0.2528,"impliedVolPercentile":0.3714},"requestUrl":"/m/hq/s/01099","defaultTab":"news","newsList":[{"id":"1199768115","title":"SINOPHARM: BlackRock, Inc. Acquires Shares via Security Interest, Long Position Rises to 9.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1199768115","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199768115?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:35","pubTimestamp":1790933719,"startTime":"0","endTime":"0","summary":"On September 29, 2026, BlackRock, Inc. acquired 1.03 million shares of SINOPHARM (H shares) by way of taking a security interest in shares, an off-exchange transaction involving non-cash assets (not...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a44b570a4bc942c79569e09a943adc8c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110251209","title":"SINOPHARM: FMR LLC Disposes of Shares, Long Position Falls to 3.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110251209","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110251209?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:24","pubTimestamp":1790673854,"startTime":"0","endTime":"0","summary":"On September 24, 2026, FMR LLC disposed of 24.02 million shares of SINOPHARM (01099) off-exchange at an average of HKD 14.661 per share, involving about HKD 352.17 million, cutting its holding below...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191497499","title":"Lazard Asset Management LLC Trims 738,800 Shares in Sinopharm (01099) at Approximately HK$15.1 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1191497499","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191497499?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:08","pubTimestamp":1790507292,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 21, Lazard Asset Management LLC reduced its holdings in Sinopharm (01099) by 738,800 shares at a price of HK$15.1035 per...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099","BK1197","LU1115378108.SGD","LU0640798160.USD","BK1500","EWH","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164509239","title":"FMR LLC Trims Sinopharm Stake by 732,400 Shares at About HK$15.01 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1164509239","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164509239?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:08","pubTimestamp":1790507291,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 21, FMR LLC reduced its holdings in Sinopharm (SEHK: 01099) by 732,400 shares at a price of HK$15.0147 per share, for a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1115378108.SGD","01099","LU0640798160.USD","BK1515","BK1500","EWH","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149734378","title":"Sinopharm: Lazard Asset Management LLC Disposes of Shares, Long Position Falls to 13.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149734378","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149734378?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:42","pubTimestamp":1790329354,"startTime":"0","endTime":"0","summary":"On September 21, 2026, Lazard Asset Management LLC sold 738,800 shares of SINOPHARM (01099) on the SEHK open market at an average of HKD 15.1035 per share, involving about HKD 11.16 million. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156012591","title":"SINOPHARM: FMR LLC Disposes of Shares, Long Position Falls to 5.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156012591","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156012591?lang=en_us&edition=fundamental","pubTime":"2026-09-25 17:25","pubTimestamp":1790328330,"startTime":"0","endTime":"0","summary":"On September 21, 2026, FMR LLC sold 732,400 shares of SINOPHARM (01099) (H shares) on the SEHK open market at an average of HKD 15.0147 per share, involving about HKD 11.00 million. The transaction...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669463557","title":"Sinopharm Group Stock Sheds 1.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2669463557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669463557?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:32","pubTimestamp":1790238720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 1.0% to 14.91 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 24761.13.Sinopharm Group Co. Ltd. closed 33% below its 52-week high of HK$22.34, which the company reached Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.5%.Trading volume totaled 3.3 million shares, compared to the 50-day average of 4.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK1593","LU1115378108.SGD","SHTDY","BK1191","BK1515","LU0640798160.USD","BK0187","BK1197","BK4175","BK0096","600196","BK1500","BK0188","BK0183","02196","BK0060","BK0239","BK0175","01099","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177969661","title":"Lazard Asset Management Boosts Stake in SINOPHARM with HK$15 Million Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1177969661","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177969661?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:26","pubTimestamp":1789043175,"startTime":"0","endTime":"0","summary":"Hong Kong Exchange filings show that on September 4, Lazard Asset Management LLC increased its holdings in SINOPHARM (01099) by 959,600 shares, at an average price of HK$15.6782 per share, for a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","LU1115378108.SGD","EWH","BK1500","BK1515","LU0640798160.USD","01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170251282","title":"SINOPHARM: Lazard Asset Management LLC Acquires, Long Position Rises to 14.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170251282","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170251282?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:11","pubTimestamp":1789031483,"startTime":"0","endTime":"0","summary":"On September 4, 2026, Lazard Asset Management LLC bought 959,600 shares of SINOPHARM (H shares) at an average of HKD 15.6782 per share, involving about HKD 15.04 million.Prior to the acquisition,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","BK0175","BK1191","BK0060","BK0183","BK1515","SHTDY","BK0012","BK1500","BK0196","01099","LU0640798160.USD","BK0028","LU1115378108.SGD","BK0188","02196","BK1593","600196","BK0239","BK1197","BK0187","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665900313","title":"Sinopharm Group Stock Rallies 0.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665900313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665900313?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. inched 0.9% higher to 15.83 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's third consecutive day of gains.Sinopharm Group Co. Ltd. closed 29% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 7.1%.Trading volume totaled 4.5 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0239","BK1500","BK4175","600196","BK0060","01099","BK1191","BK1593","02196","BK0183","BK0096","BK0028","SHTDY","LU1115378108.SGD","BK0187","BK0012","LU0640798160.USD","BK1515","BK1197","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121042106","title":"Sinopharm’s August 2026 HKEX Filing Confirms Unchanged Share Capital and Full Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1121042106","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121042106?lang=en_us&edition=fundamental","pubTime":"2026-09-04 17:48","pubTimestamp":1788515334,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. released its Monthly Return for Equity Issuer for the period ended 31 August 2026, confirming a stable capital structure with no changes in either authorised or issued share...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","BK0028","BK1515","BK0175","BK0096","BK1197","BK0187","SHTDY","BK1191","BK0183","01099","BK0239","BK1500","600196","LU0640798160.USD","BK0196","BK1593","LU1115378108.SGD","BK0012","BK0188","BK4175","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159293459","title":"Sinopharm Schedules 15 September 2026 EGM to Vote on Full Board Re-election","url":"https://stock-news.laohu8.com/highlight/detail?id=1159293459","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159293459?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:22","pubTimestamp":1788171774,"startTime":"0","endTime":"0","summary":"Sinopharm Group Co. Ltd. has circulated a proxy form for an Extraordinary General Meeting (EGM) to be held at 9:00 a.m. on 15 September 2026 in Meeting Room 1401, Sinopharm Group Building, No. 385...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076539","title":"Sinopharm Group Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076539?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:05","pubTimestamp":1788167143,"startTime":"0","endTime":"0","summary":"Sinopharm Group announces extraordinary general meetingSinopharm will hold an extraordinary general meeting in Shanghai on Sept. 15, 2026.Shareholders will vote on re-electing the board for its sevent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL297pyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01099","LU1115378108.SGD","LU0640798160.USD","BK1500","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663075548","title":"Sinopharm Proposes Re-Electing Jin Bin as Chairman for Seventh Board Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2663075548","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663075548?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:40","pubTimestamp":1788165611,"startTime":"0","endTime":"0","summary":"Sinopharm proposes re-electing Jin Bin as chairman for seventh board termSinopharm set an extraordinary general meeting for Sept. 15, 2026 to vote on re-electing directors for its seventh board term.E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL71v6pd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640798160.USD","BK1500","SHTDY","BK1197","BK1515","01099","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073083","title":"Sinopharm Group Stock Slides 2.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073083","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663073083?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.7% to 15.50 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.Sinopharm Group Co. Ltd. closed 31% short of its 52-week high of HK$22.34, which the company achieved Feb. 25.Despite its losses, the stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 3.1%.Trading volume totaled 8.7 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","01099","BK1197","LU0640798160.USD","BK1500","LU1115378108.SGD","SHTDY","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184320342","title":"Sinopharm's Subsidiary Reports 6.06 Billion Yuan Net Profit for First Half, Down 8.97% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1184320342","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184320342?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911216,"startTime":"0","endTime":"0","summary":"SINOPHARM (01099) has released the interim results of its subsidiary, China National Accord Medicines Corporation Ltd., for the six months ended June 30, 2026.The subsidiary recorded total operating...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0175","BK0196","BK1500","BK1197","LU1115378108.SGD","000028","BK0185","BK0082","BK0028","BK0010","BK1515","01099","LU0640798160.USD","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065042","title":"Sinopharm Accord, Sinopharm Group Unit, Posts H1 Net Profit Attributable to Shareholders Down 8.97% to RMB 606.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065042","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065042?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:44","pubTimestamp":1787910262,"startTime":"0","endTime":"0","summary":"Sinopharm Accord, Sinopharm Group unit, posts H1 net profit attributable to shareholders down 8.97% to RMB 606.2 millionSinopharm Accord, a subsidiary of Sinopharm Group Co. Ltd., posted 1H 2026 reven","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL93NrPf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0175","BK0196","BK1500","BK1197","LU1115378108.SGD","000028","BK0185","BK0082","BK0028","BK0010","BK1515","01099","LU0640798160.USD","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662771265","title":"Analysts Have Been Trimming Their Sinopharm Group Co. Ltd. (HKG:1099) Price Target After Its Latest Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662771265","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662771265?lang=en_us&edition=fundamental","pubTime":"2026-08-27 14:45","pubTimestamp":1787813109,"startTime":"0","endTime":"0","summary":"Shareholders might have noticed that Sinopharm Group Co. Ltd. ( HKG:1099 ) filed its interim result this time last...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/analysts-have-been-trimming-their-sinopharm-group-co-ltd-hkg","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1099/sinopharm-group-shares/news/analysts-have-been-trimming-their-sinopharm-group-co-ltd-hkg","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","FEBU","BK1197","DECU","VOTE","GXDW","RGLO","01099","PMDE","LU0640798160.USD","VGFPF","JOYT","BK1500","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinopharmgroup.com.cn","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0398},{"period":"3month","weight":-0.1201},{"period":"6month","weight":-0.2601},{"period":"1year","weight":-0.1727},{"period":"ytd","weight":-0.2037}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Sinopharm Group Co Ltd is a China-based company principally engaged in the wholesale and retail of pharmaceutical and healthcare products and medical devices. The Company operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.004652},{"month":2,"riseRate":0.588235,"avgChangeRate":0.029404},{"month":3,"riseRate":0.470588,"avgChangeRate":0.00701},{"month":4,"riseRate":0.411765,"avgChangeRate":0.016475},{"month":5,"riseRate":0.588235,"avgChangeRate":-0.009205},{"month":6,"riseRate":0.411765,"avgChangeRate":-0.006214},{"month":7,"riseRate":0.529412,"avgChangeRate":-0.008781},{"month":8,"riseRate":0.411765,"avgChangeRate":0.005041},{"month":9,"riseRate":0.411765,"avgChangeRate":-0.012951},{"month":10,"riseRate":0.611111,"avgChangeRate":0.039446},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.00729},{"month":12,"riseRate":0.529412,"avgChangeRate":-0.004119}],"exchange":"SEHK","name":"SINOPHARM","nameEN":"SINOPHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"SINOPHARM,01099,SINOPHARM股票,SINOPHARM股票老虎,SINOPHARM股票老虎国际,SINOPHARM行情,SINOPHARM股票行情,SINOPHARM股价,SINOPHARM股市,SINOPHARM股票价格,SINOPHARM股票交易,SINOPHARM股票购买,SINOPHARM股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SINOPHARM(01099),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest SINOPHARM(01099) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}